Subscribe
Be the first with the news that moves the market- Curaleaf Holdings Inc. (CURA) has received approval to begin adult-use sales at its Stamford, Connecticut location
- The new location will begin operating this Saturday at 814 East Main St and is the company’s first dispensary in the state
- The dispensary’s selection of cannabis goods will be made up of Curaleaf’s whole flower, pre-rolls, edibles, topicals, tinctures, vapes, and Curaleaf’s vape hardware, Cliq by Select
- Existing medical patients will have priority access to the dispensary through a separate entrance
- Curaleaf Holdings Inc. (CURA) is up 0.21 per cent, trading at $4.77 per share at 11:00 a.m. EST
Curaleaf Holdings (CURA) has received approval from the Connecticut Department of Consumer Protection to begin adult-use sales at its Stamford, Connecticut location.
The new location will begin operating this Saturday and is the company’s first dispensary in the state. Curaleaf stated it as a part of an opening offer, it will have vendor-sponsored giveaways, product discounts, music, and complimentary food and drinks.
According to the company, the dispensary’s selection of cannabis goods will be made up of Curaleaf’s whole flower, pre-rolls, edibles, topicals, tinctures, vapes, and Curaleaf’s vape hardware, Cliq by Select.
Matt Darin, CEO of Curaleaf, commented,
“As we welcome new adult-use customers, I want to assure our medical patients that they will continue to be prioritized and receive the high quality of care they are accustomed to.”
At Curaleaf Stamford, existing medical patients will have priority access to the dispensary through a separate entrance, experience quicker check-ins, and have a separate line for check-out. In addition, medical patients will have access to Curaleaf’s compassionate care plan, outstanding pharmacy team, and patient consult rooms.
Curaleaf has medical services at three other dispensaries across the state located in Hartford, Milford and Groton. The company anticipates welcoming adult-use customers at additional locations soon, pending regulatory approvals.
Curaleaf Holdings Inc. (CURA) is up 0.21 per cent, trading at $4.77 per share at 11:00 a.m. EST.
